Evidence map›Paper›PMID 30708351›Full record

ArticleAging2019

Xue-Ning Shen, Dan Miao, Jie-Qiong Li, Chen-Chen Tan, Xi-Peng Cao, Lan Tan, Jin-Tai Yu

Open access · greenAbstract read
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Further validation of the association betweenFrontiers in molecular neuroscience · 2024
    Article
  3. Review
  4. Review
  5. Tauopathies: new perspectives and challenges.Molecular neurodegeneration · 2022
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Xue-Ning ShenDepartment of Neurology, Huashan Hospital, Fudan University, Shanghai, China; Institute of Neurology, Fudan University, Shanghai, China.
Dan MiaoDepartment of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
Jie-Qiong LiDepartment of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
Chen-Chen TanDepartment of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
Xi-Peng CaoClinical Research Center, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
Lan TanDepartment of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
Jin-Tai YuDepartment of Neurology, Huashan Hospital, Fudan University, Shanghai, China; Institute of Neurology, Fudan University, Shanghai, China.
Qingdao Municipal Hospital · CNQingdao University · CNAlzheimer’s Disease Neuroimaging Initiative · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

The microtubule-associated protein tau gene (

Indexed as

AgedAged, 80 and overAmyloid beta-PeptidesApolipoprotein E4CarbolinesCase-Control StudiesCognitive DysfunctionFemaleHeterozygoteHippocampusHumansMaleMiddle AgedPolymorphism, Single NucleotidePositron-Emission Tomographytau Proteins7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indoleAmyloid beta-PeptidesApolipoprotein E4CarbolinesMAPT protein, humantau ProteinsAlzheimer’s diseaseF-AV-1451 PET 18hippocampusMAPTnon-dementedtauopathy

Identifiers

PMID30708351
PMCPMC6382414
OpenAlexW2913550177

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.